In addition to tumorigenesis, reduction of NRAS using siRNA or miR-146a reduced the proliferation rate and increased apoptosis in human umbilical vein endothelial cells (HUVECs), resulting in further involvement in peripartum cardiomyopathy [42]. This evidence concerns the gene NRAS and peripartum cardiomyopathy.